Radiation/nuclear medical countermeasure (MCM) product development support services: task order b-2, animal model development and initial efficacy testing of candidate mcms, 9/30/16-8/31/20

Ended Awarded Last action

Contract number
HHSN27200005
Awardee
Awarding agency
Obligated
$7,905,977

Award facts

Opportunity
Contract value 100% obligated
$7,905,977.22 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00010 -$31,360
Other Administrative Action P00009 · To revise article c.1. Statement of work and section j - list of attachments. $0
Other Administrative Action P00008 · To revise article b.3. Advance understandings, subcontract to increase the amount and extend the terms of the subcontract with citoxlab. $0
Other Administrative Action 7 $0
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $7,937,337
Show all 11

About this award

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 22, 2016, with a ceiling value of $7.9 million for radiation and nuclear medical countermeasure product development support services under a cost-plus-fixed-fee pricing structure.

The delivery order, Task Order B-2, covers animal model development and initial efficacy testing of candidate medical countermeasures, with performance at Sri International's Menlo Park, California location. The order runs through August 31, 2020. Work includes development support across the full scope of medical countermeasure candidate evaluation and testing protocols in animal models to establish initial product efficacy. No set-aside was used.

Quick answers

Who was awarded contract HHSN27200005?

HHSN27200005 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 22, 2016.

How much is contract HHSN27200005 worth?

The government has obligated $7,905,977 on HHSN27200005.

Is contract HHSN27200005 an order under another contract?

Yes. HHSN27200005 is a delivery order under HHSN272201500013I, an indefinite delivery contract.

Was contract HHSN27200005 competed?

The extent of competition for HHSN27200005 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login